mschwarz	10.1200/jco.2016.34.4_suppl.278	<http://dx.doi.org/10.1200/jco.2016.34.4_suppl.278>; rel="canonical"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.1200/jco.2016.34.4_suppl.278"><j.1:doi>10.1200/jco.2016.34.4_suppl.278</j.1:doi><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/roderich-schwarz-3fg0tiinm58uh"><j.3:name>Roderich Schwarz</j.3:name><j.3:familyName>Schwarz</j.3:familyName><j.3:givenName>Roderich</j.3:givenName></j.3:Person></j.0:creator><j.0:identifier>10.1200/jco.2016.34.4_suppl.278</j.0:identifier><j.1:volume>34</j.1:volume><j.2:pageEnd>278</j.2:pageEnd><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/niranjan-awasthi-3fg0tiinm58uh"><j.3:name>Niranjan Awasthi</j.3:name><j.3:familyName>Awasthi</j.3:familyName><j.3:givenName>Niranjan</j.3:givenName></j.3:Person></j.0:creator><owl:sameAs rdf:resource="doi:10.1200/jco.2016.34.4_suppl.278"/><j.2:pageStart>278</j.2:pageStart><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/0732-183X"><j.1:issn>1527-7755</j.1:issn><j.2:issn>1527-7755</j.2:issn><owl:sameAs>urn:issn:1527-7755</owl:sameAs><owl:sameAs>urn:issn:0732-183X</owl:sameAs><j.0:title>Journal of Clinical Oncology</j.0:title><j.1:issn>0732-183X</j.1:issn><j.2:issn>0732-183X</j.2:issn></j.2:Journal></j.0:isPartOf><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#gYearMonth" >2016-02</j.0:date><j.2:volume>34</j.2:volume><j.1:endingPage>278</j.1:endingPage><j.1:startingPage>278</j.1:startingPage><owl:sameAs rdf:resource="info:doi/10.1200/jco.2016.34.4_suppl.278"/><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/margaret-a-schwarz-3fg0tiinm58uh"><j.3:name>Margaret A. Schwarz</j.3:name><j.3:familyName>Schwarz</j.3:familyName><j.3:givenName>Margaret A.</j.3:givenName></j.3:Person></j.0:creator><j.0:publisher>American Society of Clinical Oncology (ASCO)</j.0:publisher><j.2:doi>10.1200/jco.2016.34.4_suppl.278</j.2:doi><j.0:title>Adding targeted inhibition of PI3K and MAPK signaling pathways to standard chemotherapy in experimental pancreatic cancer.</j.0:title></rdf:Description></rdf:RDF>
